| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $761.7M | — | +33.9% |
| Cost of Revenue | $232.7M | — | +45.4% |
| Gross Profit | $529.1M | — | +29.4% |
| R&D Expense | $89.7M | — | +50.5% |
| SG&A Expense | $317.2M | — | +21.7% |
| Operating Income | $122.1M | — | +37.5% |
| Pre-tax Income | $113.0M | — | +134.9% |
| Income Tax | $21.9M | — | +72.4% |
| Net Income | $91.1M | — | +157.3% |
| EPS (Basic) | $1.30 | — | +160.0% |
| EPS (Diluted) | $1.30 | — | +160.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $544.7M | +5.4% | — |
| Inventory | $462.5M | +2.2% | +4.9% |
| Current Assets | $1.71B | -10.7% | -26.6% |
| Total Assets | $2.99B | -6.4% | -15.1% |
| Current Liabilities | $687.5M | +1.1% | +32.1% |
| Long-term Debt | $929.5M | -0.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $113.8M | — | +78.4% |
| Capital Expenditures | $24.3M | — | +97.6% |
| Investing Cash Flow | -$27.7M | — | -76.4% |
| Financing Cash Flow | -$319.9M | — | -215.2% |
| Free Cash Flow | $89.5M | — | +73.8% |
| -42.3% |
| Total Liabilities | $1.68B | +0.6% | -23.0% |
| Stockholders' Equity | $1.30B | -14.0% | -2.1% |